Menopause in Aesthetics (MiA) announces their headline sponsor as Roseway Labs for their third year running.

Menopause in Aesthetics (MiA) announces their headline sponsor as Roseway Labs for their third year running.

Menopause in Aesthetics (MiA) are delighted to announce that Roseway Labs will be back as the Headline Sponsor for the third year running. 

Since the inception of Menopause in Aesthetics in 2023, Roseway Labs has been supporting the conference with its mission to enhance education within the medical and aesthetics industry in order to effectively treat menopausal symptoms.

Charlotte Body, Founder of MiA, commented on the great news: 

“We’re really excited that Roseway Labs will be our Headline Sponsor. Roseway Labs are the perfect partner for Menopause in Aesthetics in supporting our education and growth. We look forward to collaborating with their fabulous team for another spectacular event.”.

Roseway Labs is an award-winning compounding pharmacy offering a range of personalised, licensed and unlicensed medications to private doctors and patients.

Roseway Labs is dedicated to enhancing the quality of life for menopausal women through personalised, compounded medication solutions. By partnering with healthcare professionals, they ensure that menopausal patients receive the most effective and individualised treatments available.

Speaking on their sponsorship with Menopause in Aesthetics, Elizabeth Philp, CEO and Founder of Roseway Labs said:

“We are excited to continue our partnership with Menopause in Aesthetics as the Headline Sponsor. At Roseway Labs, we believe that education and collaboration are key to transforming the way menopausal symptoms are treated in the aesthetics and medical fields. Together, we’re driving innovation and empowering practitioners to deliver more personalised and effective care for women at every stage of their journey.”

Miriam Martinez Callejas, Roseway Labs’ Superintendent Pharmacist and Founder, said:

“This year we are launching a survey among healthcare professionals to gather insights into their awareness, understanding, and perceptions of treating menopausal symptoms. This survey aims to explore their knowledge of treatment options, confidence levels in managing menopause, and attitudes toward various therapies, with the goal of identifying areas for improvement and education in clinical practice.”

Miriam will be speaking in the conference programme, alongside the Roseway Labs team, who will be on hand in the exhibition hall for delegates to connect with and discover how their services can elevate their practices’ offerings

This partnership will support Menopause in Aesthetics in their goal to champion aesthetic practitioners as menopause first responders. 

Now in its third year, MIA 2025 brings a wealth of experts to the stage for a day packed with learning and professional development. Attendees will have access to up to 15 CPD hours, equipping them with the knowledge and skills necessary to effectively integrate menopause support into their clinics, and become menopause ‘first responders’.

Menopause in Aesthetics unique hybrid ticketing offers both online and in-person delegate options, plus recordings provided post-event so you don’t need to miss a minute. Don’t miss out on a chance to secure your place at this sell-out, CPD accredited event. Reserve your delegate place for 2025 - Menopause in Aesthetics tickets are now live on www.menopauseia.co.uk.